ALCHEMIST: Adjuvant targeted therapy or immunotherapy for high risk resected NSCLC (Alliance)
- Citation:
- J Clin Oncol vol 38 (15_suppl) TPS9077
- Meeting Instance:
- ASCO 2020
- Year:
- 2020
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3488
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171; U10CA180820 (ECOG-ACRIN); U10CA180888 (SWOG);
- Corr. Author:
- Authors:
- Jacob Sands Geoffrey R. Oxnard David Kozono Sumithra J. Mandrekar Shauna L. Hillman Suzanne E. Dahlberg Jamie E. Chaft Ramaswamy Govindan David E. Gerber Jhanelle Gray Shakun Malik Margaret Mooney Pasi A. Jänne Everett E. Vokes Dennis A. Wigle David R. Gandara Suresh S. Ramalingam Thomas E. Stinchcombe
- Networks:
- FL065, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC010, LAPS-NY016, LAPS-TX011
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- Alliance-A081105, Alliance-A151216, Alliance-A081801
- Phases:
- 3, N/A
- Keywords: